Navigation Links
Silence Therapeutics Announces Subscription and Open Offer to Raise up to £5.7 Million
Date:7/11/2012

27 July

Latest time and date for receipt of Forms of Proxy and electronic proxy

appointments via the CREST system    10.00 a.m. on 29 July

Results of the Fundraising announced through the RIS    31 July

General Meeting    10.00 a.m. on 31 July

Record date for Share Capital Reorganisation    5.00 p.m. on 31 July

Sub-division of Existing Ordinary Shares    5.00 p.m. on 31 July

Admission and commencement of dealings of the New Ordinary Shares    1 August

New Ordinary Shares credited to CREST stock accounts    1 August

Despatch of definitive share certificates for New Ordinary Shares    within 14 days of Admission

Notes:

(1)    References to times in this Announcement are to London time (unless otherwise stated).

(2)    If any of the above times or dates should change, the revised times and/or dates will be notified by an announcement to an RIS.

(3)    The dates and timing of the events in the above timetable and in the rest of this Announcement is indicative only and may be subject to change.

Defined terms in this announcement take the same meaning as set out in the Circular.

For further information please contact:

Silence plc Tel: +44-(0)20-7491-6520 Jerry Randall, Chairman Anthony Sedgwick, CEO Max Herrmann, CFO Singer Capital Markets Ltd Tel: +44-(0)20-3205-7500 Shaun Dobson Claes Spång M: Communications Tel: +44-(0)20-7920-2345 Sarah Macleod Claire Dickinson Darwin Strategic Tel: +44-(0)20-7938-5754 Anand Sambasivan / Jamie Vickers

 


'/>"/>
SOURCE Silence Therapeutics Plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
2. Silence Therapeutics Announces Board Changes and Appointment of New Chief Executive Officer
3. Silence Therapeutics Additional Listing
4. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
5. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
6. Nektar Therapeutics Announces Private Placement of $125 Million of Senior Secured Notes Due in 2017
7. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
8. Global Neuroendocrine Carcinoma Therapeutics Market To Reach $475m By 2019 - Report
9. United Therapeutics Announces Additional $100 Million Share Repurchase Program
10. Healthpoint Biotherapeutics To Create State-of-the-Art Cell Sciences Manufacturing Facility
11. ResearchMoz: Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar- Market Research Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... September 23, 2014 Follow ... gaining steady popularity the world over, due to ... Growth in the marketplace is expected to come ... in developing countries. Several sub-Saharan countries in the ... have already implemented genetically engineered crop production strategies. ...
(Date:9/23/2014)... TORONTO , Sept. 23, 2014 /PRNewswire/ - Portage ... Canadian Securities Exchange: PBT.U), is pleased to announce ... (PPL) has added two more  consultants to its ... uveitis. PPL-003 uses a new proprietary cell permeable ... deliver its anti-inflammatory cargo into the eye. ...
(Date:9/23/2014)... September 23, 2014 Equashield ... Transfer     Devices  (CSTD) for hazardous ... MedFront Medical Technology Corporation.  Equashield,s leading CSTD has ... Taiwan , China ... continues to expand globally, and throughout the ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 ... the globe will convene at the Society ... to be held October 26-28 in Houston, ... research and practice in individualized integrative cancer ... researchers, nurses, psychologists, nutritionists, naturopaths, acupuncturists, and ...
Breaking Biology Technology:Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 4Portage Announces New Consultants for its PPL-003 Development Programs 2Portage Announces New Consultants for its PPL-003 Development Programs 3Portage Announces New Consultants for its PPL-003 Development Programs 4Equashield Enters Taiwan Following Expansion to Australia, Japan, China 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 3
... 16 Cepheid (Nasdaq:,CPHD) today announced that it ... Northrop Grumman for the purchase of up to ... associated materials. The,anthrax test is currently used in ... Service (USPS) mail processing centers,nationwide. The agreement covers ...
... Presentations on the Topic of Drug Repurposing and ... Indian Clinical ... Inc., an,oncology-focused, clinical-stage biopharmaceutical company, announced today,that Chief Executive Officer, ... present at the 234th American Chemical,Society National Meeting on Sunday, ...
... Vermed Sale, SAN DIEGO, Aug. 16 CardioDynamics,International ... of,impedance cardiography (ICG) technology, today announced that the,shareholder vote ... over 50%,of the necessary shareholder votes (approximately 27% of ... The ratio of votes,received is running in excess of ...
Cached Biology Technology:Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems 2Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems 3Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA 2Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA 3CardioDynamics Provides 2007 Shareholder Meeting Update 2CardioDynamics Provides 2007 Shareholder Meeting Update 3
(Date:9/23/2014)... 2014 Research and Markets  has announced ... and Opportunities, 2019" report to their offering. ... enhancing security and protection in private as well as ... country,s government is focusing on using biometric systems to ... national IDs that are of crucial importance to the ...
(Date:9/23/2014)... including humans, have parasitic DNA fragments called "jumping genes" ... in the process. And that phenomenon can result in ... University of Rochester now report that the "jumping genes" ... a multi-function protein stops keeping them in check in ... a study published today in Nature Communications , ...
(Date:9/22/2014)... Conn. Yale University researchers are studying a potential ... a respiratory disease in which scars develop in the ... a microRNA mimic, miR-29, which is delivered to lung ... pulmonary fibrosis, it reversed fibrosis after several days. ... journal EMBO Molecular Medicine . , "The mimic, ...
Breaking Biology News(10 mins):India Biometrics Market Forecast and Opportunities, 2019 2India Biometrics Market Forecast and Opportunities, 2019 3A multi-function protein is key to stopping genomic parasites from 'jumping' 2Reversing the effects of pulmonary fibrosis 2
... of the latest full range survey indicate that tiger ... coordinators of a 2005 winter effort to count the ... After a massive winter endeavor to determine distribution and ... last stronghold of Siberian tigers, researchers report that approximately ...
... Oregon National Primate Research Center, Oregon Health & Science ... potential to counteract some negative impacts of smoking in ... born to mothers who continue to smoke throughout pregnancy ... current edition of the American Journal of Respiratory and ...
... of spinocerebellar ataxiaResearchers have discovered how the abnormal repetition ... lead to the death of neurons that govern balance ... that neurodegenerative disorders can be caused by having extra ... one. , People who are afflicted with the rare ...
Cached Biology News:Siberian tigers hang tough 2Siberian tigers hang tough 3OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies 2OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies 3Pinpointing the cause of a neurodegenerative disorder 2Pinpointing the cause of a neurodegenerative disorder 3
... ingredient in Molecular Probes. SlowFadeAntifade Kits ... act as a free radical scavenger ... original SlowFade formulation (S-2828) was designed ... fluorescein to almost zero (Figure 1); ...
b6-2A12...
... prepared with pure chemicals according to our ... is designed to isolating intact and active ... One kit is consisted of reagents enough ... 10 20 g tissue or from ...
... is Tecans new Enzyme-Linked Immunosorbent Assay (ELISA) ... EVOlyzer is a dedicated EVO platform for ... washer and incubation units operated by the ... is available in three sizes - 100, ...
Biology Products: